These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Euchromatin histone-lysine N-methyltransferase 2 regulates the expression of potassium-sodium-activated channel subfamily T member 1 in primary sensory neurons and contributes to remifentanil-induced pain sensitivity. Zhang Q; Ding R; Li Y; Qiao D; Kang J; Zong L; Li Y; Yuan Y; Jiao Y; Wang C; Yu Y; Zhang L; Li Y Brain Res Bull; 2024 Jun; 212():110966. PubMed ID: 38670469 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of a Dorsal Root Ganglion-Specifically Enriched Long Noncoding RNA is Required for Neuropathic Pain by Negatively Regulating RALY-Triggered Ehmt2 Expression. Pan Z; Du S; Wang K; Guo X; Mao Q; Feng X; Huang L; Wu S; Hou B; Chang YJ; Liu T; Chen T; Li H; Bachmann T; Bekker A; Hu H; Tao YX Adv Sci (Weinh); 2021 Jul; 8(13):e2004515. PubMed ID: 34383386 [TBL] [Abstract][Full Text] [Related]
6. Cannabinoid CB2 receptors are upregulated via bivalent histone modifications and control primary afferent input to the spinal cord in neuropathic pain. Ghosh K; Zhang GF; Chen H; Chen SR; Pan HL J Biol Chem; 2022 Jun; 298(6):101999. PubMed ID: 35500651 [TBL] [Abstract][Full Text] [Related]
8. HDAC2 in Primary Sensory Neurons Constitutively Restrains Chronic Pain by Repressing α2δ-1 Expression and Associated NMDA Receptor Activity. Zhang J; Chen SR; Zhou MH; Jin D; Chen H; Wang L; DePinho RA; Pan HL J Neurosci; 2022 Nov; 42(48):8918-8935. PubMed ID: 36257688 [TBL] [Abstract][Full Text] [Related]
9. Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. Mitrirattanakul S; Ramakul N; Guerrero AV; Matsuka Y; Ono T; Iwase H; Mackie K; Faull KF; Spigelman I Pain; 2006 Dec; 126(1-3):102-14. PubMed ID: 16844297 [TBL] [Abstract][Full Text] [Related]
10. G9a inhibits CREB-triggered expression of mu opioid receptor in primary sensory neurons following peripheral nerve injury. Liang L; Zhao JY; Gu X; Wu S; Mo K; Xiong M; Marie Lutz B; Bekker A; Tao YX Mol Pain; 2016; 12():. PubMed ID: 27927796 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490 [TBL] [Abstract][Full Text] [Related]
12. Role of primary sensory neurone cannabinoid type-1 receptors in pain and the analgesic effects of the peripherally acting agonist CB-13 in mice. Ford NC; Barpujari A; He SQ; Huang Q; Zhang C; Dong X; Guan Y; Raja SN Br J Anaesth; 2022 Jan; 128(1):159-173. PubMed ID: 34844727 [TBL] [Abstract][Full Text] [Related]
13. Continuous Intrathecal Infusion of Cannabinoid Receptor Agonists Attenuates Nerve Ligation-Induced Pain in Rats. Shiue SJ; Peng HY; Lin CR; Wang SW; Rau RH; Cheng JK Reg Anesth Pain Med; 2017; 42(4):499-506. PubMed ID: 28492437 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neuron in ganglion explant cultures and in a neuropathic pain model. Cruz Duarte P; St-Jacques B; Ma W Exp Neurol; 2012 Apr; 234(2):466-81. PubMed ID: 22309829 [TBL] [Abstract][Full Text] [Related]
15. Central and peripheral sites of action for CB₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats. Hsieh GC; Pai M; Chandran P; Hooker BA; Zhu CZ; Salyers AK; Wensink EJ; Zhan C; Carroll WA; Dart MJ; Yao BB; Honore P; Meyer MD Br J Pharmacol; 2011 Jan; 162(2):428-40. PubMed ID: 20880025 [TBL] [Abstract][Full Text] [Related]
16. Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity. Sideris A; Piskoun B; Russo L; Norcini M; Blanck T; Recio-Pinto E Mol Pain; 2016; 12():. PubMed ID: 27206660 [TBL] [Abstract][Full Text] [Related]
17. A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain. Yu XH; Cao CQ; Martino G; Puma C; Morinville A; St-Onge S; Lessard É; Perkins MN; Laird JMA Pain; 2010 Nov; 151(2):337-344. PubMed ID: 20696525 [TBL] [Abstract][Full Text] [Related]
18. Contribution of the Suppressor of Variegation 3-9 Homolog 1 in Dorsal Root Ganglia and Spinal Cord Dorsal Horn to Nerve Injury-induced Nociceptive Hypersensitivity. Zhang J; Liang L; Miao X; Wu S; Cao J; Tao B; Mao Q; Mo K; Xiong M; Lutz BM; Bekker A; Tao YX Anesthesiology; 2016 Oct; 125(4):765-78. PubMed ID: 27483126 [TBL] [Abstract][Full Text] [Related]
19. Pannexin-1 Up-regulation in the Dorsal Root Ganglion Contributes to Neuropathic Pain Development. Zhang Y; Laumet G; Chen SR; Hittelman WN; Pan HL J Biol Chem; 2015 Jun; 290(23):14647-55. PubMed ID: 25925949 [TBL] [Abstract][Full Text] [Related]
20. [The cannabinoid system and pain: towards new drugs?]. Beltramo M J Soc Biol; 2009; 203(1):99-106. PubMed ID: 19358815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]